Brefeldin A-induced alterations in processing of MHC class II-Ii complex depend upon microtubular function

American Journal of Hematology

Volumn 54, Issue 4, 1997, Pages 282-287

  Nguyen, Quoc V ^a   King, Rebecca L ^a  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

Brefeldin A; MHC class II li; Nocodazole

Indexed keywords

1 DEOXYMANNONOJIRIMYCIN; BREFELDIN A; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NOCODAZOLE; SWAINSONINE;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL; MICROTUBULE; MOLECULAR WEIGHT; PRIORITY JOURNAL;

BIOLOGICAL TRANSPORT; BREFELDIN A; CELL LINE; CYCLOPENTANES; GOLGI APPARATUS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; MICROTUBULES; NOCODAZOLE; PROTEIN SYNTHESIS INHIBITORS;

EID: 0030934445     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199704)54:4<282::AID-AJH4>3.0.CO;2-R     Document Type: Article

References (26)

1. Fujiwara T, Oda K, Yokota S, Takatsuki AY: Brefeldin A causes disassembly of the Golgi complex and accumulation of secretory proteins in the endoplasmic reticulum. J Biol Chem 263:18545-18552, 1988.
2. Lippincott-Schwartz J, Yuan LC, Bonafacino JS, Klausner RD: Rapid redistribution of Golgi proteins into the ER in cells treated with brefeldin A: Evidence for membrane cycling from Golgi to ER. Cell 56: 801-813, 1989.
3. Lippincott-Schwartz J, Donaldson JG, Schweizer A, Berger EG, Hauri HP, Yuan LC, Klausner RD: Microtubule-dependent retrograde transport of proteins into the ER in the presence of brefeldin A suggests an ER recycling pathway. Cell 60:821-836, 1990.
4. Doms RW, Russ G, Yewdell JW: Brefeldin A redistributes resident and itinerant Golgi proteins to the endoplasmic reticulum. J Cell Biol 109:61-72, 1989.
5. Spiro RC, Freeze HH, Sampath D, Garcia JA: Uncoupling of chondroitin sulfate glycosaminoglycan synthesis by brefeldin A. J Cell Biol 115:1463-1473, 1991.
6. Adorini L, Ullrich SJ, Appella E, Fuchs S: Inhibition by brefeldin A of presentation of exogenous protein antigens to MHC class II-restricted T cells. Nature 346:63-66, 1990.
7. Nuchtern JG, Bonifacino JS, Biddison WE, Klausner RD: Brefeldin A implicates egress from endoplasmic reticulum in class I-restricted antigen presentation. Nature 339:223-226, 1989.
8. Pal R, Munibauer S, Hoke GM, Takatsuki A, Sarngadharan MG: Brefeldin A inhibits the processing and secretion of envelope glycoproteins of human immunodeficiency virus type 1. AIDS Res Hum Retroviruses 7:707-712, 1991.
9. Cheung P, Banfield BW, Tufaro F: Brefeldin A arrests the maturation and egress of herpes simplex virus particles during infection. J Virol 65:1893-1904, 1991.
10. Eggers M, Bogner E, Agricola B, Kern HF, Radsak K: Inhibition of human cytomegalovirus maturation by brefeldin A. J Gen Virol 73: 2679-2692, 1992.
11. Whealy ME, Card JP, Meade RP, Robbins AK, Enquist LW: Effect of brefeldin A on alphaherpesvirus membrane protein glycosylation and virus egress. J Virol 65:1066-1081, 1991.
12. De Brabander MJ, Von de Veire RML, Serts FEM, Borgers M, Janssen PNJ: The effect of methyl S(2-thienyl-carbonyl) H-benzimidazolyl-2 carbamate, a new synthetic antitumoral drug interfering with microtubules, on mammalian cells cultured in vitro. Cancer Res 36:905-916, 1976.
13. Elliott WL, Stille CJ, Thomas LJ, Humphreys RE: An hypothesis on the binding of an amphipathic, alpha helical sequence in Ii to the desetope of class II antigens. J Immunol 138:2949-2952, 1987.
14. Guagliardi LE, Koppelman B, Blum JS, Marks MS, Cresswell P, Brodsky FM: Co-localization of molecules involved in antigen processing and presentation in an early endocytic compartment. Nature 343:133-139, 1990.
15. Lotteau V, Teyton L, Peleraux A, Nilsson T, Karlsson L, Schmid SL, Quaranta V, Peterson PA: Intracellular transport of class II MHC molecules directed by invariant chain. Nature 348:600-605, 1990.
16. Amigorena S, Drake JR, Webster P, Mellman I: Transient accumulation of new class II MHC molecules in a novel endocytic compartment in B lymphocytes. Nature 369:113, 1994.
17. Amigorena S, Webster P, Drake J, Newcomb J, Cresswell P, Mellman I: Invariant chain cleavage and peptide loading in major histocompatibility complex class II vesicles. J Exp Med 181:1729, 1995.
18. Quaranta V, Majdic O, Stingl G, Liszka K, Honigsmann H, Knapp WA: Human Ia cytoplasmic determinant located on multiple forms of invariant chain (gamma, gamma 2, gamma 3). J Immunol 132:1900-1905, 1984.
19. Rudd CE, Bodmer JG, Bodmer WF, Crumpton MJ: HLA-D region antigen-associated invariant polypeptides as revealed by two-dimensional gel analysis. Glycosylation and structural interrelationships. J Biol Chem 260:1927-1936, 1985.
20. Nguyen QV, Reyes VE. Humphreys RE: Structural analysis of invariant chain subsets as a function of their association with MHC class II chains. Arch Biochem Biophys 317:128-132, 1995.
21. Spiro RC, Casteal HE, Laufer DM, Reisfeld RA, Harper JR: Post-translational addition of chondroitin sulfate glycosaminoglycans. Role of N-linked oligosaccharide addition, trimming, and processing. J Biol Chem 264:1779-1786, 1989.
22. Kornfield R, Kornfield S: Assembly of asparagine-linked oligosaccharides. Annu Rev Biochem 52:631-664, 1985.
23. Chege NW, Pfeffer SR: Compartmentation of the Golgi complex: Brefeldin-A distinguishes trans-Golgi cisternae from the trans-Golgi network. J Cell Biol 111:893-899, 1990.
24. Sreenivasan V, Ng KL, Ng ML: Brefeldin A affects West Nile virus replication in Vero cells but not C6/36 cells. J Virol Methods 45:1-17, 1993.
25. Cooper DS: Antithyroid drugs. N Engl J Med 311:1353-1362, 1984.
26. Singer DS, Kohn LD, Zinger H, Mozes E: Methimazole prevents induction of experimental systemic lupus erythematosus in mice. J Immunol 153:873-880, 1994.